Export 2409 results:
[ Author(Desc)] Title Type Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A
de Almeida, S. F., Fleming, J. V., Azevedo, J. E., Carmo-Fonseca, M., & De Sousa, M. (2007). Stimulation of an unfolded protein response impairs MHC class I expression. Journal of Immunology, 178(6), 3612 - 3619.
Almeida, A., Correia-da-Silva, G., Cepa, M., Bell, S. C., & Teixeira, N. A. (2007). Synergistic induction of apoptosis in primary rat decidual cells by INF-γ and TNF. Molecular Reproduction and Development, 74(3), 371 - 377.
Almeida, T., Alonso, I., Martins, S., Ramos, E. M., et al. (2009). Ancestral origin of the ATTCT repeat expansion in spinocerebellar ataxia type 10 (SCA10). PLoS ONE, 4(2).
Almeida, A. M., Villalobos, E., Araújo, S. S., Leyman, B., et al. (2005). Transformation of tobacco with an Arabidopsis thaliana gene involved in trehalose biosynthesis increases tolerance to several abiotic stresses. Euphytica, 146(1-2), 165 - 176.
Almeida, L., Kashdan, T. B., Coelho, R., Albino-Teixeira, A., & Soares-Da-Silva, P. (2008). Healthy subjects volunteering for phase I studies: Influence of curiosity, exploratory tendencies and perceived self-efficacy. International Journal of Clinical Pharmacology and Therapeutics, 46(3), 109 - 118.
de Almeida, S. F., Carvalho, I. F., Cardoso, C. S., Cordeiro, J. V., et al. (2005). HFE cross-talks with the MHC class I antigen presentation pathway. Blood, 106(3), 971 - 977.
Almeida, A., Leite-Almeida, H., & Tavares, I. (2006). Medullary control of nociceptive transmission: Reciprocal dual communication with the spinal cord. Drug Discovery Today: Disease Mechanisms, 3(3), 305 - 312.
Almeida, M. S., & Quintanilha, A. (2017). Of responsible research—Exploring the science-society dialogue in undergraduate training within the life sciences. Biochemistry and Molecular Biology Education, 45(1), 46 - 52.
Almeida, H., Matos, L., & Neves, D. (2007). Caspase-3 and Bcl-2 expression in aging in adrenal zona reticularis after dexamethasone administration. Annals of the New York Academy of Sciences (Vol. 1119, pp. 190 - 195).
Almeida, L., Loureiro, A. I., Vaz-Da-Silva, M., Torrão, L., et al. (2010). Chronopharmacology of nebicapone, a new catechol-O-methyltransferase inhibitor. Current Medical Research and Opinion, 26(5), 1097 - 1108.
Almeida, M. R., & Saraiva, M. J. (2012). Clearance of extracellular misfolded proteins in systemic amyloidosis: Experience with transthyretin. FEBS Letters, 586(18), 2891 - 2896.
de Almeida, S. F., Picarote, G., Fleming, J. V., Carmo-Fonseca, M., et al. (2007). Chemical chaperones reduce endoplasmic reticulum stress and prevent mutant HFE aggregate formation. Journal of Biological Chemistry, 282(38), 27905 - 27912.
Almeida, B., Sampaio-Marques, B., Carvalho, J., Silva, M. T., et al. (2007). An atypical active cell death process underlies the fungicidal activity of ciclopirox olamine against the yeast Saccharomyces cerevisiae. FEMS Yeast Research, 7(3), 404 - 412.
Almeida, T., Marques, M., Mojzita, D., Amorim, M. A., et al. (2008). Isc1p plays a key role in hydrogen peroxide resistance and chronological lifespan through modulation of iron levels and apoptosis. Molecular Biology of the Cell, 19(3), 865 - 876.
Almeida, L., Falcão, A., Vaz-Da-Silva, M., Nunes, T., et al. (2008). Effect of nebicapone on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects. European Journal of Clinical Pharmacology, 64(10), 961 - 966.
Almeida, M. R., Gales, L., Damas, A. M., Cardoso, I., & Saraiva, M. J. (2005). Small transthyretin (TTR) ligands as possible therapeutic agents in TTR amyloidoses. Current Drug Targets: CNS and Neurological Disorders, 4(5), 587 - 596.
Almeida, C. M., Manso, J. A., Figueiredo, A. C., Antunes, L., et al. (2017). Functional and structural characterization of synthetic cardosin B-derived rennet. Applied Microbiology and Biotechnology, 101(18), 6951 - 6968.
Almeida, M. R., Macedo, B., Cardoso, I., Alves, I., et al. (2004). Selective binding to transthyretin and tetramer stabilization in serum from patients with familial amyloidotic polyneuropathy by an iodinated diflunisal derivative. Biochemical Journal, 381(2), 351 - 356.
Almeida, L., Kashdan, T. B., Nunes, T., Coelho, R., et al. (2008). Who volunteers for phase I clinical trials? Influences of anxiety, social anxiety and depressive symptoms on self-selection and the reporting of adverse events. European Journal of Clinical Pharmacology, 64(6), 575 - 582.
Almeida, H., Matos, L., Ferreira, J., & Neves, D. (2006). Age-related effects of dexamethasone administration in adrenal zona reticularis. Annals of the New York Academy of Sciences (Vol. 1067, pp. 354 - 360).
Almeida, L., Vaz-Da-Silva, M., Coelho, R., Albino-Teixeira, A., & Soares-Da-Silva, P. (2009). Interpersonal values of healthy subjects who volunteer for phase I clinical trials. Pharmaceutical Medicine, 23(5-6), 299 - 303.
Almeida, L., Vaz-Da-Silva, M., Falcão, A., Soares, E., et al. (2009). Pharmacokinetic and safety profile of trans-resveratrol in a rising multiple-dose study in healthy volunteers. Molecular Nutrition and Food Research, 53(SUPPL. 1), S7 - S15.
Almeida, H., Ferreira, J., & Neves, D. (2004). Macrophages of the adrenal cortex: A morphological study of the effects of aging and dexamethasone administration. Annals of the New York Academy of Sciences (Vol. 1019, pp. 135 - 140).
de Almeida, S. F., & De Sousa, M. (2008). The unfolded protein response in hereditary haemochromatosis: Molecular Medicine. Journal of Cellular and Molecular Medicine, 12(2), 421 - 434.
Almeida, L., Falcão, A., Vaz-Da-Silva, M., Coelho, R., et al. (2008). Personality characteristics of volunteers in phase 1 studies and likelihood of reporting adverse events. International Journal of Clinical Pharmacology and Therapeutics, 46(7), 340 - 348.

Pages


Home | Site Map | Contacts | Credits | Privacy & Cookies | Intranet | Social Networks |


rua alfredo allen, 208, 4200-135 porto - portugal | tel +351 220 408 800 | email: info@i3s.up.pt | © copyright 2010 ibmc